Distribution properties of lentiviral vectors administered into the striatum by convection-enhanced delivery

Human Gene Therapy

Volumn 23, Issue 1, 2012, Pages 115-127

  White, Edward ^a,b   Bienemann, Alison ^b   Megraw, Lisa ^b   Bunnun, Chotirote ^b   Wyatt, Marcella ^b   Taylor, Hannah ^b   Gill, Steven ^a,b  

^a FRENCHAY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; EQUINE INFECTIOUS ANEMIA VIRUS VECTOR; HEPARIN; HUMAN IMMUNODEFICIENCY VIRUS VECTOR; LENTIVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONVECTION ENHANCE DELIVERY; CORPUS STRIATUM; DRUG DELIVERY SYSTEM; EQUINE INFECTIOUS ANEMIA VIRUS; GENE EXPRESSION; HISTOPATHOLOGY; MALE; NONHUMAN; RAT; REPORTER GENE; SWINE; TROPISM;

ANIMALS; BETA-GALACTOSIDASE; CONVECTION; CORPUS STRIATUM; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HEPARIN; HIV; INFECTIOUS ANEMIA VIRUS, EQUINE; LENTIVIRUS; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; NIMODIPINE; RATS; RATS, WISTAR; SWINE; VESICULAR STOMATITIS INDIANA VIRUS; VIRAL ENVELOPE PROTEINS;

ANIMALIA; EQUINE INFECTIOUS ANEMIA VIRUS; LENTIVIRUS; RATTUS; SUIDAE;

EID: 84855906863     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2010.185     Document Type: Article

References (45)

1. Auer, L.M., and Mokry, M. (1986). Effect of topical nimodipine versus its ethanol-containing vehicle on cat pial arteries. Stroke 17, 225-228. (Pubitemid 16125244)
2. Azzouz, M., Ralph, G.S., Storkebaum, E., et al. (2004). VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429, 413-417. (Pubitemid 38715132)
3. Bechmann, I., Galea, I., and Perry, V.H. (2007). What is the blood-brain barrier (not)? Trends Immunol. 28, 5-11. (Pubitemid 46001619)
4. Boulton, M., Flessner, M., Armstrong, D., et al. (1999). Contribution of extracranial lymphatics and arachnoid villi to the clearance of a CSF tracer in the rat. Am. J. Physiol. 276, R818-R823. (Pubitemid 29157512)
5. Brewer, G.J., Torricelli, J.R., Evege, E.K., and Price, P.J. (1993). Optimized survival of hippocampal neurons in B27-supple-mented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35, 567-576. (Pubitemid 23215708)
6. Brizard, M., Carcenac, C., Bemelmans, A.P., et al. (2006). Functional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease. Neurobiol. Dis. 21, 90-101. (Pubitemid 41817309)
7. Chen, M.Y., Hoffer, A., Morrison, P.F., et al. (2005). Surface properties, more than size, limiting convective distribution of virus-sized particles and viruses in the central nervous system. J. Neurosurg. 103, 311-319. (Pubitemid 43193908)
8. Consiglio, A., Quattrini, A., Martino, S., et al. (2001). In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: Correction of neuropathology and protection against learning impairments in affected mice. Nat. Med. 7, 310-316. (Pubitemid 32224346)
9. Cserr, H.F., and Patlak, C.S. (1992). Secretion and bulk flow of interstitial fluid. In Physiology and Pharmacology of the Blood-Brain Barrier. M.W.B. Bradbury, ed. (Springer, Berlin) pp. 245-261.
10. Cunningham, J., Oiwa, Y., Nagy, D., et al. (2000). Distribution of AAV-TK following intracranial convection-enhanced delivery into rats. Cell Transplant. 9, 585-594. (Pubitemid 32002567)
11. Cunningham, J., Pivirotto, P., Bringas, J., et al. (2008). Biodis-tribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brain. Mol. Ther. 16, 1267-1275. (Pubitemid 351866058)
12. Dore-Duffy, P., Katychev, A., Wang, X., and Van Buren, E. (2006). CNS microvascular pericytes exhibit multipotential stem cell activity. J. Cereb. Blood Flow Metab. 26, 613-624.
13. Dowd, E., Monville, C., Torres, E.M., et al. (2005). Lentivector-mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model. Eur. J. Neurosci. 22, 2587-2595. (Pubitemid 41759001)
14. Eberling, J.L., Jagust, W.J., Christine, C.W., et al. (2008). Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology 70, 1980-1983.
15. Fiandaca, M.S., Forsayeth, J.R., Dickinson, P.J., and Bankiewicz, K.S. (2008). Image-guided convection-enhanced delivery platform in the treatment of neurological diseases. Neurother-apeutics 5, 123-127. (Pubitemid 350299297)
16. Fiandaca, M.S., Varenika, V., Eberling, J., et al. (2009). Real-time MR imaging of adeno-associated viral vector delivery to the primate brain. Neuroimage 47(Suppl. 2), T27-T35.
17. Fjord-Larsen, L., Johansen, J.L., Kusk, P., et al. (2005). Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct. Exp. Neurol. 195, 49-60. (Pubitemid 41116813)
18. Guibinga, G.H., Miyanohara, A., Esko, J.D., and Friedmann, T. (2002). Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells. Mol. Ther. 5, 538-546. (Pubitemid 34546083)
19. Hadaczek, P., Kohutnicka, M., Krauze, M.T., et al. (2006). Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain. Hum. Gene Ther. 17, 291-302.
20. Hadaczek, P., Forsayeth, J., Mirek, H., et al. (2009). Transduction of nonhuman primate brain with adeno-associated virus se-rotype 1: Vector trafficking and immune response. Hum. Gene Ther. 20, 225-237.
21. Kaplitt, M.G., Feigin, A., Tang, C., et al. (2007). Safety and tol-erability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: An open label, phase I trial. Lancet 369, 2097-2105. (Pubitemid 46935946)
22. Kordower, J.H., Emborg, M.E., Bloch, J., et al. (2000). Neurode-generation prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290, 767-773.
23. Krauze, M.T., Forsayeth, J., Park, J.W., and Bankiewicz, K.S. (2006). Real-time imaging and quantification of brain delivery of liposomes. Pharm. Res. 23, 2493-2504. (Pubitemid 44691597)
24. Lonser, R.R., Schiffman, R., Robison, R.A., et al. (2007). Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease. Neurology 68, 254-261. (Pubitemid 46148336)
25. Marchand, C.F., and Schwab, M.E. (1986). Binding, uptake and retrograde axonal transport of herpes virus suis in sympathetic neurons. Brain Res. 383, 262-270. (Pubitemid 17179981)
26. Mardor, Y., Rahav, O., Zauberman, Y., et al. (2005). Convection-enhanced drug delivery: Increased efficacy and magnetic resonance image monitoring. Cancer Res. 65, 6858-6863. (Pubitemid 41065083)
27. Mazarakis, N.D., Azzouz, M., Rohll, J.B., et al. (2001). Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum. Mol. Genet. 10, 2109-2121. (Pubitemid 32998823)
28. McCoy, M.K., Ruhn, K.A., Martinez, T.N., et al. (2008). In-tranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats. Mol. Ther. 16, 1572-1579.
29. McIntyre, C., Derrick Roberts, A.L., Ranieri, E., et al. (2008). Lentiviral-mediated gene therapy for murine mucopoly-saccharidosis type IIIA. Mol. Genet. Metab. 93, 411-418.
30. Nguyen, J.B., Sanchez-Pernaute, R., Cunningham, J., and Bank-iewicz, K.S. (2001). Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain. Neuroreport 12, 1961-1964. (Pubitemid 32553715)
31. Passini, M.A., Macauley, S.L., Huff, M.R., et al. (2005). AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease. Mol. Ther. 11, 754-762. (Pubitemid 40567980)
32. Sanftner, L.M., Sommer, J.M., Suzuki, B.M., et al. (2005). AAV2-mediated gene delivery to monkey putamen: Evaluation of an infusion device and delivery parameters. Exp. Neurol. 194, 476-483. (Pubitemid 40967005)
33. Schley, D., Carare-Nnadi, R., Please, C.P., et al. (2006). Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J. Theor. Biol. 238, 962-974. (Pubitemid 43175842)
34. Segura, M.M., Kamen, A., and Garnier, A. (2006). Downstream processing of oncoretroviral and lentiviral gene therapy vectors. Biotechnol. Adv. 24, 321-337.
35. Spencer, B., Marr, R.A., Rockenstein, E., et al. (2008). Long-term neprilysin gene transfer is associated with reduced levels of intracellular Ab and behavioral improvement in APP trans-genic mice. BMC Neurosci. 9, 109.
36. Suzuki, M., Obara, K., Sasaki, Y., et al. (2003). Comparison of perivascular astrocytic structure between white matter and gray matter of rats. Brain Res. 992, 294-297. (Pubitemid 37415113)
37. Szentistvanyi, I., Patlak, C.S., Ellis, R.A., and Cserr, H.F. (1984). Drainage of interstitial fluid from different regions of rat brain. Am. J. Physiol. 246, F835-F844. (Pubitemid 14075694)
38. Szerlip, N.J., Walbridge, S., Yang, L., et al. (2007). Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles. J. Neurosurg. 107, 560-567. (Pubitemid 47451040)
39. Thorne, R.G., and Nicholson, C. (2006). In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space. Proc. Natl. Acad. Sci. U.S.A. 103, 5567-5572.
40. Torashima, T., Koyama, C., Iizuka, A., et al. (2008). Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia. EMBO Rep. 9, 393-399.
41. Vercammen, L., Van der Perren, A., Vaudano, E., et al. (2006). Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease. Mol. Ther. 14, 716-723. (Pubitemid 44507714)
42. Weller, R.O., Kida, S., and Zhang, E.T. (1992). Pathways of fluid drainage from the brain: Morphological aspects and immu-nological significance in rat and man. Brain Pathol. 2, 277-284.
43. White, E., Bienemann, A., Sena-Esteves, M., et al. (2011). Evaluation and optimization of the administration of recombinant adeno-associated viral vectors (serotypes 2/1, 2/2, 2/rh8, 2/9, and 2/rh10) by convection-enhanced delivery to the striatum. Hum. Gene Ther. 22, 237-251.
44. Wong, L.F., Ralph, G.S., Walmsley, L.E., et al. (2005). Lentiviral-mediated delivery of Bcl-2 or GDNF protects against ex-citotoxicity in the rat hippocampus. Mol. Ther. 11, 89-95. (Pubitemid 40012002)
45. Yanez-Munoz, R.J., Balaggan, K.S., MacNeil, A., et al. (2006). Effective gene therapy with nonintegrating lentiviral vectors. Nat. Med. 12, 348-353. (Pubitemid 43355085)